← FDA DRUG APPROVALS

FDA ANDA · ANDA090712

POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES

Sponsor: PADDOCK LLC

APPLICATION
ANDA090712
TYPE
ANDA
ORIGINAL APPROVAL
2010-02-25
LATEST ACTION
2010-02-25
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued

Products

POLYETHYLENE GLYCOL 3350 AND ELECTROLYTESDiscontinued
POLYETHYLENE GLYCOL 3350 240GM/BOT, POTASSIUM CHLORIDE 2.98GM/BOT, SODIUM BICARBONATE 6.72GM/BOT, SODIUM CHLORIDE 5.84GM/BOT, SODIUM SULFATE ANHYDROUS 22.72GM/BOT · FOR SOLUTION · ORAL

Approval history

2010-02-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →